β-adrenergic receptors (β-ARs) are model G-protein coupled receptors that mediate signal transduction in the sympathetic nervous system. Despite the widespread clinical use of agents that target β-ARs, the signaling pathways that operate downstream of β-AR stimulation have not yet been completely elucidated. Here, we utilized a lysate microarray approach to obtain a broad-scale perspective of phosphoprotein signaling downstream of β-AR. We monitored the time course of phosphorylation states of 54 proteins after β-AR activation mouse embryonic fibroblast (MEF) cells. In response to stimulation with the non-selective β-AR agonist isoproterenol, we observed previously described phosphorylation events such as ERK1/2(T202/Y204) and CREB(S133), b...
The aim of this study was to test the possible modification of beta-adrenergic receptor kinase (beta...
A key question in receptor signaling is how specificity is realized, particularly when different rec...
<p>MEFs were pretreated with the β1-AR antagonist CGP 20712A (CGP) and β2-AR antagonist ICI 118,551 ...
β-adrenergic receptors (β-ARs) are model G-protein coupled receptors that mediate signal transductio...
G protein-coupled receptor signaling is dynamically regulated by multiple feedback mechanisms, which...
β-adrenergic receptor (β-AR) stimulation represents a major mechanism of modulating cardiac output. ...
Introduction: Recently, it has been found that different ligands can have distinct efficacy profiles...
A growing body of evidence has demonstrated that p38 mitogen-activated protein kinase (MAPK) has a c...
We analyzed the kinetic and spatial patterns characterizing activation of the MAP kinases ERK 1 and ...
AbstractWe analyzed the kinetic and spatial patterns characterizing activation of the MAP kinases ER...
G protein-coupled receptors (GPCRs) activate mitogen-activated protein kinases through a number of d...
We analyzed the kinetic and spatial patterns characterizing activation of the MAP kinases ERK 1 and ...
Sustained β-adrenergic receptors (βAR) activation leads to cardiac hypertrophy and prevents left ven...
AbstractPhosphorylation of G-protein-coupled receptors by second-messenger-stimulated kinases is cen...
Authors acknowledge funding from Deutsche Forschungsgemeinschaft (DFG; German Research Foundation) c...
The aim of this study was to test the possible modification of beta-adrenergic receptor kinase (beta...
A key question in receptor signaling is how specificity is realized, particularly when different rec...
<p>MEFs were pretreated with the β1-AR antagonist CGP 20712A (CGP) and β2-AR antagonist ICI 118,551 ...
β-adrenergic receptors (β-ARs) are model G-protein coupled receptors that mediate signal transductio...
G protein-coupled receptor signaling is dynamically regulated by multiple feedback mechanisms, which...
β-adrenergic receptor (β-AR) stimulation represents a major mechanism of modulating cardiac output. ...
Introduction: Recently, it has been found that different ligands can have distinct efficacy profiles...
A growing body of evidence has demonstrated that p38 mitogen-activated protein kinase (MAPK) has a c...
We analyzed the kinetic and spatial patterns characterizing activation of the MAP kinases ERK 1 and ...
AbstractWe analyzed the kinetic and spatial patterns characterizing activation of the MAP kinases ER...
G protein-coupled receptors (GPCRs) activate mitogen-activated protein kinases through a number of d...
We analyzed the kinetic and spatial patterns characterizing activation of the MAP kinases ERK 1 and ...
Sustained β-adrenergic receptors (βAR) activation leads to cardiac hypertrophy and prevents left ven...
AbstractPhosphorylation of G-protein-coupled receptors by second-messenger-stimulated kinases is cen...
Authors acknowledge funding from Deutsche Forschungsgemeinschaft (DFG; German Research Foundation) c...
The aim of this study was to test the possible modification of beta-adrenergic receptor kinase (beta...
A key question in receptor signaling is how specificity is realized, particularly when different rec...
<p>MEFs were pretreated with the β1-AR antagonist CGP 20712A (CGP) and β2-AR antagonist ICI 118,551 ...